Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07348237
PHASE1

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.

Official title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-2828 in Participants With Renal Impairment

Key Details

Gender

All

Age Range

24 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-03-02

Completion Date

2026-08-18

Last Updated

2026-04-02

Healthy Volunteers

Yes

Interventions

DRUG

MK-2828

Oral administration

Locations (3)

Panax Clinical Research ( Site 0003)

Miami Lakes, Florida, United States

Floridian Clinical Research ( Site 0001)

Miami Lakes, Florida, United States

Orlando Clinical Research Center ( Site 0002)

Orlando, Florida, United States